Harvard Bioscience (HBIO) Amortization - Intangibles (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Amortization - Intangibles data on file, last reported at $820000.0 in Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $820000.0, down 29.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (down 27.45% YoY), and the FY2025 annual result was $4.0 million, down 23.37% from the prior year.
• Amortization - Intangibles retreated to $820000.0 in Q1 2026 per HBIO's latest filing, from $850000.0 in the prior quarter.
• Over five years, Amortization - Intangibles peaked at $1.6 million in Q4 2022 and troughed at $820000.0 in Q1 2026.
• A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Amortization - Intangibles.
• The sharpest annual moves came in 2022 and 2025: Amortization - Intangibles climbed 13.19% in 2022, then tumbled 35.91% in 2025.
• A 5-year view of Amortization - Intangibles shows it stood at $1.6 million in 2022, then fell by 14.91% to $1.4 million in 2023, then fell by 9.37% to $1.3 million in 2024, then sank by 32.38% to $850000.0 in 2025, then slipped by 3.53% to $820000.0 in 2026.
• Business Quant data shows HBIO's Amortization - Intangibles at $820000.0 in Q1 2026, $850000.0 in Q4 2025, and $855000.0 in Q3 2025.